Freshpet (FRPT) CEO William Cyr sells 94K shares, exercises 168K options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Freshpet, Inc. CEO William B. Cyr reported a series of option exercises and share sales in Freshpet common stock. On May 15 and May 18, 2026, he exercised options to acquire a total of 168,000 shares at a $10.23 exercise price and sold 94,364 shares in open-market transactions.
The sales occurred at weighted average prices generally between about $47.81 and $51.68 per share. Following these transactions, Cyr holds 227,815 shares of common stock directly, with additional indirect holdings through his spouse and family trusts. The sales were effected under a Rule 10b5-1 trading plan adopted on November 5, 2025, and the options exercised were granted under the company’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 94,364 shares ($4,638,365)
Net Sell
29 txns
Insider
Cyr William B.
Role
Chief Executive Officer
Sold
94,364 shs ($4.64M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Options to purchase common stock | 62,369 | $0.00 | -- |
| Exercise | Options to purchase common stock | 4,620 | $0.00 | -- |
| Exercise | Options to purchase common stock | 9,030 | $0.00 | -- |
| Exercise | Options to purchase common stock | 7,981 | $0.00 | -- |
| Exercise | Common Stock | 62,369 | $10.23 | $638K |
| Sale | Common Stock | 32,344 | $48.46 | $1.57M |
| Sale | Common Stock | 1,526 | $49.09 | $75K |
| Sale | Common Stock | 7,513 | $50.36 | $378K |
| Sale | Common Stock | 1,309 | $51.32 | $67K |
| Exercise | Common Stock | 4,620 | $10.23 | $47K |
| Sale | Common Stock | 959 | $50.04 | $48K |
| Exercise | Common Stock | 9,030 | $10.23 | $92K |
| Sale | Common Stock | 1,874 | $50.04 | $94K |
| Exercise | Common Stock | 7,981 | $10.23 | $82K |
| Sale | Common Stock | 1,656 | $50.04 | $83K |
| Exercise | Options to purchase common stock | 62,369 | $0.00 | -- |
| Exercise | Options to purchase common stock | 4,620 | $0.00 | -- |
| Exercise | Options to purchase common stock | 9,030 | $0.00 | -- |
| Exercise | Options to purchase common stock | 7,981 | $0.00 | -- |
| Exercise | Common Stock | 62,369 | $10.23 | $638K |
| Sale | Common Stock | 6,104 | $48.44 | $296K |
| Sale | Common Stock | 36,289 | $49.46 | $1.79M |
| Sale | Common Stock | 300 | $49.85 | $15K |
| Exercise | Common Stock | 4,620 | $10.23 | $47K |
| Sale | Common Stock | 959 | $49.09 | $47K |
| Exercise | Common Stock | 9,030 | $10.23 | $92K |
| Sale | Common Stock | 1,874 | $49.09 | $92K |
| Exercise | Common Stock | 7,981 | $10.23 | $82K |
| Sale | Common Stock | 1,657 | $49.09 | $81K |
Holdings After Transaction:
Options to purchase common stock — 493,024 shares (Direct);
Options to purchase common stock — 36,520 shares (Indirect, By Spouse);
Common Stock — 227,815 shares (Direct);
Common Stock — 19,206 shares (Indirect, By Spouse)
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.81 to $48.74. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.81 to $49.80. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.83 to $49.89. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to $48.88. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $49.46. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.94. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.03 to $51.68. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
Key Figures
Shares sold: 94,364 shares
Options exercised: 168,000 shares
Exercise price: $10.23 per share
+5 more
8 metrics
Shares sold
94,364 shares
Total common stock sales reported in Form 4
Options exercised
168,000 shares
Total underlying common shares from option exercises
Exercise price
$10.23 per share
Exercise price for options to purchase common stock
Direct holdings after trades
227,815 shares
Common stock held directly by William B. Cyr after transactions
Sale price range (low)
$47.81 per share
Lower end of reported weighted average sale price ranges
Sale price range (high)
$51.68 per share
Upper end of reported weighted average sale price ranges
10b5-1 plan adoption date
November 5, 2025
Date CEO adopted Rule 10b5-1 trading plan
Option plan
2014 Omnibus Incentive Plan
Plan under which exercised options were granted and fully vested
Key Terms
Rule 10b5-1 trading plan, weighted average price, Options to purchase common stock, 2014 Omnibus Incentive Plan, +2 more
6 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions at prices within stated ranges."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Options to purchase common stock financial
"Options to purchase common stock with a $10.23 conversion or exercise price were exercised into common shares."
2014 Omnibus Incentive Plan financial
"The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020."
non-derivative financial
"Common Stock transactions are listed as non-derivative, reflecting trades in the underlying shares."
derivative security financial
"Exercise or conversion of derivative security is cited for the option transactions."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transactions did Freshpet (FRPT) CEO William B. Cyr report?
William B. Cyr reported both option exercises and share sales. He exercised options for 168,000 Freshpet common shares at a $10.23 exercise price and sold 94,364 shares in open-market transactions at weighted average prices around the high-$40s to low-$50s.
What stock options did the Freshpet (FRPT) CEO exercise in this filing?
Cyr exercised options to purchase 168,000 shares at a $10.23 exercise price. These options were issued under Freshpet’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020, before being exercised into common stock.